Microinflammation in the intestinal mucosa and symptoms of irritable bowel syndrome

被引:8
|
作者
Yoshimoto, Takanori [1 ]
Oshima, Tadayuki [1 ]
Huang, Xinyi [1 ]
Tomita, Toshihiko [1 ]
Fukui, Hirokazu [1 ]
Miwa, Hiroto [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan
关键词
Irritable bowel syndrome; Duodenum; Mast cell; Intraepithelial lymphocyte; MAST-CELLS; IMMUNE ACTIVATION; IBS; INFLAMMATION; ASSOCIATION; HYPERPLASIA; EXPRESSION; DEPRESSION;
D O I
10.1007/s00535-021-01838-4
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Potential etiological mechanisms of irritable bowel syndrome (IBS) have been reported, and emerging data suggest that immune activation is present in a major subset of IBS, especially in those with diarrhea. Intestinal mucosal mast cell and intraepithelial lymphocyte (IEL) infiltration and related factors were examined in patients with IBS. In addition, the correlations of symptoms and micro-inflammation were assessed. Methods Intestinal biopsy specimens were obtained from patients with IBS and controls. Mast cells and IELs were stained with specific antibodies. The mRNA levels of cytokines and chemokines were assessed by quantitative reverse transcription polymerase chain reaction. Results Infiltration of mast cells in the duodenum was significantly higher in IBS patients than in control subjects. The infiltration of IELs was higher in the duodenum and terminal ileum of IBS patients compared to the control subjects. The numbers of duodenal and ileal IELs were significantly correlated. The number of IELs but not mast cells in the duodenum and terminal ileum was significantly correlated with diarrhea frequency in control subjects and IBS patients. The expression level of the chemotactic chemokine CXCL11 was significantly higher in the duodenum of IBS patients. Conclusion Duodenal mast cells and IELs were increased in IBS patients. In addition, a positive correlation was found between the number of duodenal and ileal IELs and the frequency of diarrhea. Given that the present study was strictly observational, further studies are needed to clarify the pathophysiological functions associated with micro-inflammation in IBS.
引用
收藏
页码:62 / 69
页数:8
相关论文
共 50 条
  • [1] Microinflammation in the intestinal mucosa and symptoms of irritable bowel syndrome
    Takanori Yoshimoto
    Tadayuki Oshima
    Xinyi Huang
    Toshihiko Tomita
    Hirokazu Fukui
    Hiroto Miwa
    Journal of Gastroenterology, 2022, 57 : 62 - 69
  • [2] Nerve Fiber Outgrowth Is Increased in the Intestinal Mucosa of Patients With Irritable Bowel Syndrome
    Dothel, Giovanni
    Barbaro, Maria Raffaella
    Boudin, Helene
    Vasina, Valentina
    Cremon, Cesare
    Gargano, Luciana
    Bellacosa, Lara
    De Giorgio, Roberto
    Le Berre-Scoul, Catherine
    Aubert, Philippe
    Neunlist, Michel
    De Ponti, Fabrizio
    Stanghellini, Vincenzo
    Barbara, Giovanni
    GASTROENTEROLOGY, 2015, 148 (05) : 1002 - U456
  • [3] Prevalence of extra-intestinal symptoms according to irritable bowel syndrome subtype
    Pereyra, Facundo
    Fernandez, Luis Maria Bustos
    Schlottmann, Francisco
    Zamora, Rafael
    Marconi, Agustina
    Steinberg, Leandro
    Pereyra, Lisandro
    NEUROGASTROENTEROLOGY AND MOTILITY, 2024, 36 (07)
  • [4] Mast cells are increased in the small intestinal mucosa of patients with irritable bowel syndrome: A systematic review and meta-analysis
    Robles, Alejandro
    Ingles, David Perez
    Myneedu, Kanchana
    Deoker, Abhizith
    Sarosiek, Irene
    Zuckerman, Marc J.
    Schmulson, Max J.
    Bashashati, Mohammad
    NEUROGASTROENTEROLOGY AND MOTILITY, 2019, 31 (12)
  • [5] The microbiome of the oral mucosa in irritable bowel syndrome
    Fourie, Nicolaas H.
    Wang, Dan
    Abey, Sarah K.
    Sherwin, LeeAnne B.
    Joseph, Paule V.
    Rahim-Williams, Bridgett
    Ferguson, Eric G.
    Henderson, Wendy A.
    GUT MICROBES, 2016, 7 (04) : 286 - 301
  • [6] Using human intestinal biopsies to study the pathogenesis of irritable bowel syndrome
    Nasser, Y.
    Boeckxstaens, G. E.
    Wouters, M. M.
    Schemann, M.
    Vanner, S.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (04) : 455 - 469
  • [7] Contribution of MicroRNAs in the Development of Irritable Bowel Syndrome Symptoms
    Dupont, Pablo Thomas
    Izaguirre-Hernandez, Irma Yadira
    Troche, Jose Maria Remes
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2023, 32 (02) : 230 - 240
  • [8] Impaired intestinal molecular tightness in the mucosa of irritable bowel syndrome: what are the mediators?
    Vicario, Maria
    Alonso, Carmen
    Santos, Javier
    GUT, 2009, 58 (02) : 161 - 162
  • [9] Intestinal dysbiosis in irritable bowel syndrome: etiological factor or epiphenomenon?
    Cremon, Cesare
    Carini, Giovanni
    De Giorgio, Roberto
    Stanghellini, Vincenzo
    Corinaldesi, Roberto
    Barbara, Giovanni
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (04) : 389 - 393
  • [10] Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome
    Piche, T.
    Ducrotte, P.
    Sabate, J. M.
    Coffin, B.
    Zerbib, F.
    Dapoigny, M.
    Hua, M.
    Marine-Barjoan, E.
    Dainese, R.
    Hebuterne, X.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2010, 22 (06) : 626 - +